Innovative Solutions
for Common Eye Conditions, Dry Eye and Pink Eye.
- Pink Eye Drops
- Dry Eye Drops
- CL Rewetting Drops
ClearSight is focused on developing smarter solutions to common eye conditions. We’re on a mission to disrupt the sleepy over-the-counter (OTC) eye care industry with a novel and innovative portfolio of products.
THE PROBLEM:
Three conditions. Tens of millions affected. Billions lost every year. A problem that wont blink.Â
Every year, millions of Americans face eye conditions that may seem minor—but have a major impact on daily life, productivity, and overall well-being. From children sidelined by contagious Pink Eye to adults battling chronic Dry Eye or persistent Contact Lens Discomfort, these issues are not only disruptive—they’re widespread, costly, and often left untreated. In fact, more than 45 million people in the U.S. are affected by one or more of these preventable or manageable conditions, contributing to over $60 billion in lost productivity, medical expenses, and time away from work or school every year.
THE SOLUTION:
CS-001 Proven Artificial Tear + Powerful Antimicrobial Biopolymer.
Built on ClearSight’s proprietary platform, these drop harness the dual-action potency of a leading artificial tear and a powerful antimicrobial biopolymer.
This unique formula soothes dry, irritated eyes and combats the underlying infection, rapidly reducing redness, swelling, and discomfort.
Trusted by professionals and designed for effortless use, the next generation of pink eye care is here—fast, effective, and scientifically advanced.Â
- Anti-Bacterial Efficacy*
- Anti-Viral Efficacy*
- Anti-Fungal Efficacy*
THE SOLUTION:
CS-001 Proven Artificial Tear + Powerful Antimicrobial Biopolymer.
Built on ClearSight’s proprietary platform, these drop harness the dual-action potency of a leading artificial tear and a powerful antimicrobial biopolymer.
This unique formula soothes dry, irritated eyes and combats the underlying infection, rapidly reducing redness, swelling, and discomfort.
Trusted by professionals and designed for effortless use, the next generation of pink eye care is here—fast, effective, and scientifically advanced.Â
- Anti-Bacterial Efficacy*
- Anti-Viral Efficacy*
- Anti-Fungal Efficacy*
Dry Eye Treatment
Contact Lense Rewettng
Rewetting Drops
eye condition In-sights
Common eye conditions are a daily cause of pain and discomfort for millions of people
Dry Eye Disease
Patients with dry eyes report 30% lower work productivity, especially in screen-heavy environments.Â
-
Current OTC Options:
Artificial Tears and Lubricants
-
Key Unmet Need(s):
Low-cost Biofilm treatment
Contact Lens Rewetting
More than 1 in 5 wearers interrupt their day to remove or adjust lenses due to dryness.
-
Current OTC Options:
Active lens cleaning
-
Key Unmet Need(s):
Low-cost Biofilm treatment
Infection prevention
Acute Infectious Conjunctivitis (Pink eye)
Something that can really ruin your day, Pink Eye, (conjunctivitis) alone affects up to 6 million people in the U.S.Â
-
Current OTC Options:
Only Rx Antibiotics
-
Key Unmet Need(s):
OTC option
Anti-viral Treatment
technology
This platform allows ClearSight to develop multiple therapies targeting Dry Eye Disease, Contact Lens Rewetting Drops, and the first and only OTC treatment for Acute Infectious Conjunctivitis, better known as Pink Eye.ClearSight’s proprietary platform harnesses the dual-action potency of a leading artificial tear and a powerful antimicrobial biopolymer.Â
About ClearSight Therapeutics
OUR HISTORY
ClearSight Therapeutics was founded in 2023 by a team of eye care industry veterans and partners to develop better solutions to common eye conditions such as dry eye and pink eye, which continue to disrupt the lives of millions of patients.Â
OUR values
At ClearSight Therapeutics, we are committed to ethical and responsible biotech research and development. We believe in putting patients first, and we are dedicated to developing OTC dry eye and pink eye treatments that are safe, effective, and accessible to all. Â
Recent articles
OUR PARTNERS
Health Wildcatters was founded in 2013 to address the need for a health innovation hub in the burgeoning Dallas/Fort Worth Metroplex healthcare industry. Since its inception the Health Wildcatters portfolio has grown to 118 startups who have raised over $350 million. Health Wildcatters provides a seed investment, in-kind perks, and a vast network of mentors comprised of well over 200 individuals spanning the healthcare industry, professional services, and many other verticals.
A nonprofit, MassChallenge connects startups, experts, corporations, and communities to grow and transform businesses and economies. Our unique equity-free model allows us to accelerate high-impact startups with bold, disruptive ideas from non-traditional backgrounds.
We offer a variety of programs, accelerators, and partnerships throughout the year to those who share our vision of transformative innovation.
The center of gravity for entrepreneurs outside of Silicon Valley
Thousands of entrepreneurs, programmers and designers gather day and night, in-person and online for meetups, classes and coworking. With boots on the ground in Austin, Dallas, Houston, San Antonio, and Washington, DC we meet the best entrepreneurs outside of Silicon Valley and introduce them to investors, employees, and customers. According to Pitchbook, Capital Factory has been the most active investor in Texas since 2010.